LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

Home・Aktien・Vivani Medical

Vivani Medical

Geschlossen

1.12 -4.27

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.12

Max

1.17

Schlüsselkennzahlen
By Trading Economics
Einkommen	-147K -6.8M
Angestellte	42

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+217.8% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	11. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	10M 87M
Vorheriger Eröffnungskurs	5.39
Vorheriger Schlusskurs	1.12

Vivani Medical Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

8. Juni 2026, 22:20 UTC

Akquisitionen, Fusionen, Übernahmen

Salesforce to Buy m3ter in Nod Toward AI-Native Business Models

8. Juni 2026, 15:41 UTC

Wichtige Markttreiber

American Battery Shares Jump on Energy Department Victory

8. Juni 2026, 23:46 UTC

Market Talk

Nikkei May Rebound After Monday's Selloff -- Market Talk

8. Juni 2026, 23:37 UTC

Market Talk

Oil Edges Higher Amid Ongoing Supply Disruption Concerns -- Market Talk

8. Juni 2026, 23:25 UTC

Market Talk

Should Australia Consider State-Linked Commodities Export Desk? -- Market Talk

8. Juni 2026, 23:25 UTC

Market Talk

Global Equities Roundup: Market Talk

8. Juni 2026, 21:57 UTC

Akquisitionen, Fusionen, Übernahmen

Salesforce Expects to Close Deal in 2Q of Fiscal 2027

8. Juni 2026, 21:56 UTC

Akquisitionen, Fusionen, Übernahmen

Salesforce Agrees to Buy m3ter

8. Juni 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

8. Juni 2026, 19:22 UTC

Market Talk

Oil Settles Higher as Israel-Iran Exchanges Raise Tension -- Market Talk

8. Juni 2026, 19:01 UTC

Market Talk

U.S. Natural Gas Futures Pull Back on Weather Outlook -- Market Talk

8. Juni 2026, 18:52 UTC

Market Talk

Global Energy Roundup: Market Talk

8. Juni 2026, 18:52 UTC

Market Talk

CAD Needs Trade Deal to Trigger Sustained Rally -- Market Talk

8. Juni 2026, 18:17 UTC

Market Talk

Oil Pulls Back Further As Iran, Israel Put Strikes on Hold -- Market Talk

8. Juni 2026, 17:32 UTC

Market Talk

Bank of Canada Should Incorporate Unemployment Rate Into Its Forecast -- Market Talk

8. Juni 2026, 17:29 UTC

Market Talk

Crypto Market Still Stays in 'Extreme Fear' Amid Rebound -- Market Talk

8. Juni 2026, 17:29 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. Juni 2026, 16:55 UTC

Akquisitionen, Fusionen, Übernahmen

Monte dei Paschi: Mediobanca Integration Proceeding According to Plan

8. Juni 2026, 16:54 UTC

Akquisitionen, Fusionen, Übernahmen

Monte dei Paschi to Review Proposals From Banco BPM, Intesa Sanpaolo

8. Juni 2026, 16:40 UTC

Market Talk

Cryptocurrencies Rise After Iran and Israel Halt Exchanges of Fire -- Market Talk

8. Juni 2026, 16:31 UTC

Market Talk

No Recession in Canada, Scotiabank's CEO Says -- Market Talk

8. Juni 2026, 16:27 UTC

Market Talk

Mexican Inflation Seen Easing in May -- Market Talk

8. Juni 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8. Juni 2026, 16:03 UTC

Akquisitionen, Fusionen, Übernahmen

Orange Bought Stake From Lorca

8. Juni 2026, 16:01 UTC

Akquisitionen, Fusionen, Übernahmen

Orange Completes Acquisition of Remaining 50% Stake in MasOrange

8. Juni 2026, 16:01 UTC

Akquisitionen, Fusionen, Übernahmen

Orange Acquires 100% Ownership of MasOrange

8. Juni 2026, 15:58 UTC

Market Talk

Global Equities Roundup: Market Talk

8. Juni 2026, 15:58 UTC

Market Talk

Gold Trims Losses After Israel, Iran Halt Exchanges of Fire -- Market Talk

8. Juni 2026, 15:55 UTC

Market Talk

Markets Price Small Chance USMCA Will Be Dismantled -- Market Talk

8. Juni 2026, 15:41 UTC

Market Talk

Gold Falls Below 200-Day Moving Average -- Market Talk

Peer-Vergleich

Kursveränderung

Vivani Medical Prognose

Kursziel

By TipRanks

217.8% Vorteil

12-Monats-Prognose

Durchschnitt 3.75 USD 217.8%

Hoch 4 USD

Tief 3.5 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Vivani Medical – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

Buy

Halten

Sell

Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Vivani Medical – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

Über Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.